Stocktoria
Viatris Inc VTRS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1973-02-01
Chart by TradingView
3/9
Piotroski F — financial health
0.65
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$18.7B
P / S1.3×
P / B1.3×
P / FCF9.6×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $14.3B | $14.7B | $15.4B | $16.3B | $17.9B |
| Gross profit | $5.0B | $5.6B | $6.4B | $6.5B | $5.6B |
| Operating income | -$2.7B | $10.1M | $766.2M | $1.6B | -$34.0M |
| Operating cash flow | $2.3B | $2.3B | $2.9B | $3.0B | $3.0B |
| Free cash flow | $1.9B | $2.0B | $2.5B | $2.6B | $2.6B |
| Total assets | $37.2B | $41.5B | $47.7B | $50.0B | $54.8B |
| Total liabilities | $22.5B | $22.9B | $27.2B | $28.9B | $34.4B |
| Shareholders' equity | $14.7B | $18.6B | $20.5B | $21.1B | $20.5B |
| Ratios | |||||
| Gross margin | 35.1% | 38.2% | 41.7% | 40.0% | 31.2% |
| Operating margin | -18.6% | 0.1% | 5.0% | 9.9% | -0.2% |
| FCF margin | 13.5% | 13.4% | 16.4% | 15.9% | 14.3% |
| Debt / equity | 0.85× | 0.75× | 0.79× | 0.85× | 0.96× |
| Current ratio | 1.38 | 1.65 | 1.67 | 1.58 | 1.10 |
| Revenue growth | -3.0% | -4.5% | -5.1% | -9.1% | 49.7% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| GREENLIGHT CAPITAL INC | 3,355,770 | $36.3M |
| Point72 Asset Management, L.P. | 1,777,181 | $24.0M |
| Bridgewater Associates, LP | 725,884 | $9.8M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.65 (distress)
- Working capital / assets 0.072
- Retained earnings / assets -0.01
- EBIT / assets -0.072
- Equity / liabilities 0.654
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001792044 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.